NL7202278A - - Google Patents

Info

Publication number
NL7202278A
NL7202278A NL7202278A NL7202278A NL7202278A NL 7202278 A NL7202278 A NL 7202278A NL 7202278 A NL7202278 A NL 7202278A NL 7202278 A NL7202278 A NL 7202278A NL 7202278 A NL7202278 A NL 7202278A
Authority
NL
Netherlands
Application number
NL7202278A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE795788D priority Critical patent/BE795788A/xx
Application filed filed Critical
Priority to NL7202278A priority patent/NL7202278A/xx
Priority to ZA730839A priority patent/ZA73839B/xx
Priority to GB621973A priority patent/GB1416271A/en
Priority to AU51979/73A priority patent/AU471298B2/en
Priority to US00331945A priority patent/US3853836A/en
Priority to HUAO351A priority patent/HU168890B/hu
Priority to DE19732308362 priority patent/DE2308362A1/de
Priority to JP48021120A priority patent/JPS4896586A/ja
Priority to CH245873A priority patent/CH585192A5/xx
Priority to CA164,274A priority patent/CA1030953A/en
Priority to FR7306338A priority patent/FR2181759B1/fr
Publication of NL7202278A publication Critical patent/NL7202278A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL7202278A 1972-02-22 1972-02-22 NL7202278A (US20100012521A1-20100121-C00001.png)

Priority Applications (12)

Application Number Priority Date Filing Date Title
BE795788D BE795788A (nl) 1972-02-22 Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan
NL7202278A NL7202278A (US20100012521A1-20100121-C00001.png) 1972-02-22 1972-02-22
ZA730839A ZA73839B (en) 1972-02-22 1973-02-06 Psychopharmacologically active peptides
GB621973A GB1416271A (en) 1972-02-22 1973-02-08 Psychopharmacologically active peptides
AU51979/73A AU471298B2 (en) 1972-02-22 1973-02-08 Psychopharmacologically active peptides
US00331945A US3853836A (en) 1972-02-22 1973-02-12 Psychopharmacologically active peptides related to acth
HUAO351A HU168890B (US20100012521A1-20100121-C00001.png) 1972-02-22 1973-02-20
DE19732308362 DE2308362A1 (de) 1972-02-22 1973-02-20 Psychopharmakologisch aktive peptide und peptidderivate
JP48021120A JPS4896586A (US20100012521A1-20100121-C00001.png) 1972-02-22 1973-02-21
CH245873A CH585192A5 (US20100012521A1-20100121-C00001.png) 1972-02-22 1973-02-21
CA164,274A CA1030953A (en) 1972-02-22 1973-02-21 Psychopharmacologically active peptides
FR7306338A FR2181759B1 (US20100012521A1-20100121-C00001.png) 1972-02-22 1973-02-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7202278A NL7202278A (US20100012521A1-20100121-C00001.png) 1972-02-22 1972-02-22

Publications (1)

Publication Number Publication Date
NL7202278A true NL7202278A (US20100012521A1-20100121-C00001.png) 1973-08-24

Family

ID=19815436

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7202278A NL7202278A (US20100012521A1-20100121-C00001.png) 1972-02-22 1972-02-22

Country Status (12)

Country Link
US (1) US3853836A (US20100012521A1-20100121-C00001.png)
JP (1) JPS4896586A (US20100012521A1-20100121-C00001.png)
AU (1) AU471298B2 (US20100012521A1-20100121-C00001.png)
BE (1) BE795788A (US20100012521A1-20100121-C00001.png)
CA (1) CA1030953A (US20100012521A1-20100121-C00001.png)
CH (1) CH585192A5 (US20100012521A1-20100121-C00001.png)
DE (1) DE2308362A1 (US20100012521A1-20100121-C00001.png)
FR (1) FR2181759B1 (US20100012521A1-20100121-C00001.png)
GB (1) GB1416271A (US20100012521A1-20100121-C00001.png)
HU (1) HU168890B (US20100012521A1-20100121-C00001.png)
NL (1) NL7202278A (US20100012521A1-20100121-C00001.png)
ZA (1) ZA73839B (US20100012521A1-20100121-C00001.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US5462927A (en) * 1985-04-30 1995-10-31 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
JP2525798B2 (ja) * 1987-03-12 1996-08-21 第一製薬株式会社 ペプチド誘導体
WO1993000922A1 (en) * 1991-07-01 1993-01-21 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
US7176279B2 (en) * 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
DK1695703T3 (da) * 2000-08-25 2010-10-25 Res Corp Technologies Inc Nye anvendelser for aminosyrekrampestillende midler
CA2453515A1 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
ATE498678T1 (de) * 2004-04-08 2011-03-15 Astellas Pharma Inc Verbindung ws727713
AU2005231034B2 (en) * 2004-04-08 2010-04-08 Telsar Pharma Inc. Compound WS727713
US20130059914A1 (en) * 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
JP2023549405A (ja) * 2020-11-18 2023-11-24 マインド メディシン, インコーポレイテッド 心理療法を補助するためのmdmaプロドラッグ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL278010A (US20100012521A1-20100121-C00001.png) * 1961-05-04 1900-01-01
NL6509727A (US20100012521A1-20100121-C00001.png) * 1965-07-28 1967-01-30
GB1230472A (US20100012521A1-20100121-C00001.png) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
DE2308362A1 (de) 1973-09-06
FR2181759B1 (US20100012521A1-20100121-C00001.png) 1976-09-03
AU5197973A (en) 1974-08-08
FR2181759A1 (US20100012521A1-20100121-C00001.png) 1973-12-07
JPS4896586A (US20100012521A1-20100121-C00001.png) 1973-12-10
US3853836A (en) 1974-12-10
GB1416271A (en) 1975-12-03
HU168890B (US20100012521A1-20100121-C00001.png) 1976-08-28
AU471298B2 (en) 1976-04-15
BE795788A (nl) 1973-08-22
ZA73839B (en) 1973-11-28
CA1030953A (en) 1978-05-09
CH585192A5 (US20100012521A1-20100121-C00001.png) 1977-02-28

Similar Documents

Publication Publication Date Title
CH599136A5 (US20100012521A1-20100121-C00001.png)
CH561314A5 (US20100012521A1-20100121-C00001.png)
BG18688A1 (US20100012521A1-20100121-C00001.png)
BG19581A3 (US20100012521A1-20100121-C00001.png)
BG20764A3 (US20100012521A1-20100121-C00001.png)
CH111172A4 (US20100012521A1-20100121-C00001.png)
CH545565A (US20100012521A1-20100121-C00001.png)
CH559611A5 (US20100012521A1-20100121-C00001.png)
NL7209839A (US20100012521A1-20100121-C00001.png)
CH559879A5 (US20100012521A1-20100121-C00001.png)
CH560322A5 (US20100012521A1-20100121-C00001.png)
CH600029A5 (US20100012521A1-20100121-C00001.png)
CH562928A5 (US20100012521A1-20100121-C00001.png)
CH563094A5 (US20100012521A1-20100121-C00001.png)
CH563856A5 (US20100012521A1-20100121-C00001.png)
CH563928A5 (US20100012521A1-20100121-C00001.png)
CH565303A5 (US20100012521A1-20100121-C00001.png)
CH565318A5 (US20100012521A1-20100121-C00001.png)
CH565326A5 (US20100012521A1-20100121-C00001.png)
CH565436A5 (US20100012521A1-20100121-C00001.png)
CH565954A5 (US20100012521A1-20100121-C00001.png)
CH566030A5 (US20100012521A1-20100121-C00001.png)
CH566525A5 (US20100012521A1-20100121-C00001.png)
CH567390A5 (US20100012521A1-20100121-C00001.png)
CH567732A5 (US20100012521A1-20100121-C00001.png)